Delivery Order SPE2DB22D9207-SPE2DB25FH5BG
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order from the Defense Logistics Agency for 240 units of Alecensa 150 mg capsules, valued at $21,731.14. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation. The award represents one of numerous delivery orders issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-unit quantity). This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $51,129.28 on July 18, 2025, for Alecensa 150 mg capsules (240-count units) under a Defense Logistics Agency contract. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a single transaction within DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $12,782.32 for 240 tablets of Alecensa 150mg. The award, issued on August 28, 2025, with an ultimate completion date of September 18, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $38,346.96 on September 18, 2025, for the supply of Alecensa 150 mg capsules (240 units). The award was issued without a set-aside designation by the Medical Supply Chain division of the Defense Logistics Agency and is scheduled for ultimate completion by October 9, 2025. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a $12.78K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240 count). The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a $25.6K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 240 units of Alecensa 150 mg capsules. The contract was awarded on September 18, 2025, with an ultimate completion date of October 9, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a continuation of the companies' established relationship under the larger pharmaceutical supply framework....
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, awarded on July 21, 2025, carries a ceiling value of $12,782.32 and is scheduled for ultimate completion by August 11, 2025. The contract was awarded without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The U.S. Defense Logistics Agency (DLA), acting through the Medical Supply Chain organization, awarded a delivery order to DMS Pharmaceutical Group Inc. on June 9, 2025, for the supply of Alecensa 150 mg capsules in quantities of 240 units. This firm fixed-price delivery order, valued at $38,346.96, represents a single task issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which carries a maximum value of $499,999,999 and extends...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5BGDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for 240 capsules of Alecensa 150 mg on June 26, 2025. The contract is valued at $12,782.32 under a firm fixed-price delivery order structure with an ultimate completion date of July 18, 2025. This award was made without a set-aside designation, allowing the company to compete on an unrestricted basis. The place of performance is Park Ridge, Illinois. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency through the SPE2DB program, valued at $499,999,999 and extending through November 2026. The IDC enables the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs at military health facilities worldwide. Alecensa, a prescription oncology medication, aligns with the company's established portfolio of specialty pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently delivered critical medications to Department of Defense healthcare sites nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 6/26/25 |